Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 11, Issue 12, Pages 1405-1413
Publisher
Informa UK Limited
Online
2012-12-20
DOI
10.1586/erv.12.126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): A production process developed for a lead candidate recombinant hookworm vaccine antigen
- (2012) Gaddam Narsa Goud et al. PROTEIN EXPRESSION AND PURIFICATION
- Licensure of vaccines using the Animal Rule
- (2012) Drusilla L Burns Current Opinion in Virology
- Advances in vaccines against neglected tropical diseases
- (2012) Jordan Plieskatt et al. Human Vaccines & Immunotherapeutics
- A Handful Of ‘Antipoverty’ Vaccines Exist For Neglected Diseases, But The World’s Poorest Billion People Need More
- (2011) Peter Hotez HEALTH AFFAIRS
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends
- (2010) Stephen Hearty et al. Expert Review of Vaccines
- Developing vaccines to combat hookworm infection and intestinal schistosomiasis
- (2010) Peter J. Hotez et al. NATURE REVIEWS MICROBIOLOGY
- A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
- (2010) Lanying Du et al. VIRAL IMMUNOLOGY
- Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
- (2010) Zhiliang Cao et al. Virology Journal
- Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
- (2009) Lanying Du et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SARS vaccines: where are we?
- (2009) Rachel L Roper et al. Expert Review of Vaccines
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
- (2009) Lanying Du et al. VIROLOGY
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults
- (2008) Jeffrey M. Bethony et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started